Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma

Overview

Journal J Pers Med

Date 2023 Nov 25

PMID 38003931

Authors

Enar Jumaniyazova

Anastasiya Lokhonina

Dzhuliia Dzhalilova

Anna Kosyreva

Timur Fatkhudinov

Affiliations

Soon will be listed here.

Abstract

Head and neck squamous cell cancer (HNSCC) is one of the ten most common malignant neoplasms, characterized by an aggressive course, high recurrence rate, poor response to treatment, and low survival rate. This creates the need for a deeper understanding of the mechanisms of the pathogenesis of this cancer. The tumor microenvironment (TME) of HNSCC consists of stromal and immune cells, blood and lymphatic vessels, and extracellular matrix. It is known that HNSCC is characterized by complex relationships between cancer cells and TME components. TME components and their dynamic interactions with cancer cells enhance tumor adaptation to the environment, which provides the highly aggressive potential of HNSCC and resistance to antitumor therapy. Basic research aimed at studying the role of TME components in HNSCC carcinogenesis may serve as a key to the discovery of both new biomarkers-predictors of prognosis and targets for new antitumor drugs. This review article focuses on the role and interaction with cancer of TME components such as newly formed vessels, cancer-associated fibroblasts, and extracellular matrix.

Citing Articles

A bioengineered tumor matrix-based scaffold for the evaluation of melatonin efficacy on head and neck squamous cancer stem cells.

Andres J, Rodriguez-Santana C, de Lara-Pena L, Jimenez G, Escames G, Marchal J Mater Today Bio. 2024; 29:101246.

PMID: 39351489 PMC: 11440243. DOI: 10.1016/j.mtbio.2024.101246.

References

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

Christopoulos A, Ahn S, Klein J, Kim S . Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis. Head Neck. 2011; 33(8):1220-9. DOI: 10.1002/hed.21588. View

Nordemar S, Kronenwett U, Auer G, Hogmo A, Lindholm J, Edstrom S . Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx. Anticancer Res. 2001; 21(1B):509-12. View

Le Q, Harris J, Magliocco A, Kong C, Diaz R, Shin B . Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. J Clin Oncol. 2009; 27(26):4281-6. PMC: 2744270. DOI: 10.1200/JCO.2008.20.6003. View

el-Gazzar R, Macluskey M, Williams H, Ogden G . Vascularity and expression of vascular endothelial growth factor in oral squamous cell carcinoma, resection margins, and nodal metastases. Br J Oral Maxillofac Surg. 2005; 44(3):193-7. DOI: 10.1016/j.bjoms.2005.06.030. View

Junior H, Rocha V, Leite C, de Aguiar M, Souza P, Horta M . Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med. 2013; 43(3):199-204. DOI: 10.1111/jop.12121. View

Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, Maeda T . Acidic extracellular microenvironment and cancer. Cancer Cell Int. 2013; 13(1):89. PMC: 3849184. DOI: 10.1186/1475-2867-13-89. View

Martinez-Outschoorn U, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S . Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle. 2011; 10(15):2504-20. PMC: 3180189. DOI: 10.4161/cc.10.15.16585. View

Pradeep C, Sunila E, Kuttan G . Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther. 2005; 4(4):315-21. DOI: 10.1177/1534735405282557. View

10.

Semenza G . Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med. 2010; 2(3):336-361. DOI: 10.1002/wsbm.69. View

11.

Apte R, Chen D, Ferrara N . VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019; 176(6):1248-1264. PMC: 6410740. DOI: 10.1016/j.cell.2019.01.021. View

12.

Yan X, Cao N, Chen Y, Lan H, Cha J, Yang W . MT4-MMP promotes invadopodia formation and cell motility in FaDu head and neck cancer cells. Biochem Biophys Res Commun. 2019; 522(4):1009-1014. DOI: 10.1016/j.bbrc.2019.12.009. View

13.

Bristow R, Hill R . Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008; 8(3):180-92. DOI: 10.1038/nrc2344. View

14.

Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran M, Mammoto A . Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. Am J Pathol. 2013; 183(4):1293-1305. PMC: 3791684. DOI: 10.1016/j.ajpath.2013.06.026. View

15.

Hapke R, Haake S . Hypoxia-induced epithelial to mesenchymal transition in cancer. Cancer Lett. 2020; 487:10-20. PMC: 7336507. DOI: 10.1016/j.canlet.2020.05.012. View

16.

Niu J, Li Z . The roles of integrin αvβ6 in cancer. Cancer Lett. 2017; 403:128-137. DOI: 10.1016/j.canlet.2017.06.012. View

17.

Sanada T, Islam A, Kaminota T, Kirino Y, Tanimoto R, Yoshimitsu H . Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Laryngoscope. 2019; 130(5):E327-E334. DOI: 10.1002/lary.28142. View

18.

Tremble P, Chiquet-Ehrismann R, Werb Z . The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell. 1994; 5(4):439-53. PMC: 301053. DOI: 10.1091/mbc.5.4.439. View

19.

Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C . Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol (Camb). 2015; 7(10):1120-34. PMC: 4593730. DOI: 10.1039/c5ib00040h. View

20.

Zhang X, Dong Y, Zhao M, Ding L, Yang X, Jing Y . ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system. Theranostics. 2020; 10(26):12044-12059. PMC: 7667693. DOI: 10.7150/thno.47901. View